Asymmetric pain processing in Parkinson's disease

European Journal of Neurology

Volumn 20, Issue 10, 2013, Pages 1375-1382

  Granovsky, Y ^a,b   Schlesinger, I ^a,b   Fadel, S ^a   Erikh, I ^a   Sprecher, E ^a   Yarnitsky, D ^a,b  

^a Rambam Health Care Campus ^*  (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Conditioned pain modulation; Mesolimbic system; Pain; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEAT; HUMAN; MALE; NERVOUS SYSTEM PARAMETERS; NOCICEPTION; PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; STIMULATION;

CONDITIONED PAIN MODULATION; MESOLIMBIC SYSTEM; PAIN; PARKINSON'S DISEASE;

AGED; ANTIPARKINSON AGENTS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HYPERALGESIA; LEVODOPA; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; PARKINSON DISEASE; PSYCHOPHYSICS;

EID: 84883808168     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12188     Document Type: Article

References (32)

1. Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain 1995; 60: 3-38.
2. Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175.
3. Zambito Marsala S, Tinazzi M, Vitaliani R, et al. Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease. J Neurol 2011; 258: 627-633.
4. Schestatsky P, Kumru H, Valls-Solé J, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 2007; 69: 2162-2169.
5. Tinazzi M, Recchia S, Simonetto S, et al. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing. J Neurol Sci 2009; 276: 153-158.
6. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 2007; 78: 1140-1142.
7. Slaoui T, Mas-Gerdelat A, Ory-Magne F, Rascol O, Brefel-Courbon C. Levodopa modifies pain thresholds in Parkinson's disease patients. Rev Neurol (Paris) 2007; 163: 66-71.
8. Lim SY, Farrell MJ, Gibson SJ, et al. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? Mov Disord 2008; 23: 1689-1695.
9. Battista AF, Wolff BB. Levodopa and induced-pain response. A study of patients with Parkinsonian and pain syndromes. Arch Intern Med 1973; 132: 70-74.
10. Burkey AR, Carstens E, Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 1999; 19: 4169-4179.
11. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol 2010; 23: 611-615.
12. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 24-28.
13. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
14. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005; 20: 1557-1563.
15. Vela L, Baron M, Barriga FJ, et al. Levodopa does not raise pain-pressure threshold in Parkinson disease. Mov Disord 2006; 21(Suppl. 15): S496.
16. Hagelberg N, Jääskeläinen SK, Martikainen IK, et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 2004; 500: 187-192.
17. Coghill RC, Gilron I, Iadarola MJ. Hemispheric lateralization of somatosensory processing. J Neurophysiol 2001; 85: 2602-2612.
18. Hsieh JC, Hannerz J, Ingvar M. Right-lateralised central processing for pain of nitroglycerin-induced cluster headache. Pain 1996; 67: 59-68.
19. Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995; 63: 225-236.
20. Baliki MN, Geha PY, Fields HL, Apkarian AV. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 2010; 66: 149-160.
21. Kalivas PW, Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 1995; 675: 325-328.
22. Geha PY, Baliki MN, Harden RN, et al. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008; 60: 570-581.
23. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist 2004; 10: 221-234.
24. Baker KB, Kim JJ. Amygdalar lateralization in fear conditioning: evidence for greater involvement of the right amygdala. Behav Neurosci 2004; 118: 15-23.
25. Lalumiere RT, McGaugh JL. Memory enhancement induced by post-training intrabasolateral amygdala infusions of beta-adrenergic or muscarinic agonists requires activation of dopamine receptors: involvement of right, but not left, basolateral amygdala. Learn Mem 2005; 12: 527-532.
26. Lee GP, Meador KJ, Loring DW, et al. Neural substrates of emotion as revealed by functional magnetic resonance imaging. Cogn Behav Neurol 2004; 17: 9-17.
27. Yoshimura S, Ueda K, Suzuki SI, et al. Self-referential processing of negative stimuli within the ventral anterior cingulate gyrus and right amygdala. Brain Cogn 2008; 69: 218-225.
28. Ji G, Neugebauer V. Hemispheric lateralization of pain processing by amygdala neurons. J Neurophysiol 2009; 102: 2253-2264.
29. Tomer R, Aharon-Peretz J, Tsitrinbaum Z. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease. Neuropsychologia 2007; 45: 357-367.
30. Cilia R, Siri C, Marotta G, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 2008; 65: 1604-1611.
31. Rodriguez-Oroz MC, Jahanshahi M, Krack P, et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009; 8: 1128-1139.
32. Andrés P, Van der Linden M, Parmentier FB. Directed forgetting in working memory: age-related differences. Memory 2004; 12: 248-256.